Mather Group
VRTX icon

Mather Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Mather Group’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.46M Buy
4,698
+182
+4% +$93.2K 0.02% 246
2026
Q2 		$2.24M Buy
4,516
+78
+2% +$34.6K 0.02% 257
2026
Q1 		$1.98M Buy
4,438
+13
+0.3% +$6.06K 0.02% 227
2025
Q4 		$2.01M Buy
4,425
+86
+2% +$37.1K 0.02% 203
2025
Q3 		$1.7M Buy
4,339
+23
+0.5% +$9.6K 0.02% 218
2025
Q2 		$1.92M Buy
4,316
+170
+4% +$78.3K 0.02% 196
2025
Q1 		$2.01M Buy
4,146
+259
+7% +$121K 0.02% 182
2024
Q4 		$1.57M Sell
3,887
-128
-3% -$59.3K 0.02% 186
2024
Q3 		$1.87M Buy
4,015
+80
+2% +$38.4K 0.02% 170
2024
Q2 		$1.64M Buy
3,935
+398
+11% +$173K 0.02% 209
2024
Q1 		$1.44M Sell
3,537
-104
-3% -$44K 0.02% 179
2023
Q4 		$1.48M Buy
3,641
+49
+1% +$18.1K 0.02% 181
2023
Q3 		$1.25M Buy
3,592
+422
+13% +$148K 0.02% 187
2023
Q2 		$1.12M Buy
3,170
+287
+10% +$96.7K 0.02% 214
2023
Q1 		$908K Hold
2,883
– – 0.02% 223
2022
Q4 		$833K Buy
2,883
+102
+4% +$31.1K 0.02% 235
2022
Q3 		$805K Buy
2,781
+231
+9% +$66.5K 0.02% 226
2022
Q2 		$719K Buy
2,550
+264
+12% +$70.7K 0.02% 211
2022
Q1 		$596K Buy
+2,286
New +$543K 0.01% 233

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Davenport & Co
Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return
Montrusco Bolton Investments
Montrusco Bolton Investments Montreal, Quebec, Canada $5.77B AUM 24.61% 1-Year Est. Return
Birch Hill Investment Advisors
Birch Hill Investment Advisors Boston, Massachusetts $2.43B AUM 15.45% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
ABN AMRO Investment Solutions
ABN AMRO Investment Solutions Paris Cedex 008 $13.2B AUM 30.55% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
MN Services Vermogensbeheer
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
Czech National Bank
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

Mather Group's VRTX Position: Q3 2026 in Review

Mather Group increased its Vertex Pharmaceuticals (VRTX) stake by 4% in Q3 2026, buying an estimated $93.2K and bringing the position to 4,698 shares worth $2.46M. The position accounts for 0.02% of the portfolio, ranked #246.

Mather Group first reported a position in VRTX in Q1 2022 and has held it in 19 quarters since. 360 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • Mather Group held 4,698 shares of Vertex Pharmaceuticals worth $2.46M as of Q3 2026.
  • Mather Group bought 182 Vertex Pharmaceuticals shares in Q3 2026, an estimated $93.2K.
  • Vertex Pharmaceuticals made up 0.02% of Mather Group's portfolio in Q3 2026, its #246 holding.
  • Mather Group first reported a position in Vertex Pharmaceuticals in Q1 2022 and has held it in 19 quarters since.
  • 360 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Mather Group's 13F filing for Q3 2026, filed 14 Oct 2026.